Obesity-drug leader Eli Lilly (LLY) is within striking distance of a new buy point following a strong quarterly earnings report. That makes Eli Lilly stock Wednesday's pick for IBD 50 Growth Stocks To Watch from Investor's Business Daily. The company develops and sells medicines across diabetes, obesity, immunology, oncology and neuroscience markets. Eli Lilly stock boasts an ideal score of…